Loading organizations...
Key people at Hansen Medical.
Hansen Medical, based in Mountain View, California, USA, developed advanced medical robotics for intravascular procedures, primarily targeting physicians for cardiac electrophysiology and peripheral vascular interventions. The company's key products included the Sensei Robotic Catheter System, designed for precise control in electrophysiology, and the Magellan Robotic System, which facilitated navigation in peripheral vascular procedures. Hansen Medical became publicly traded via NASDAQ following its 2006 IPO, selling its robotic systems and related accessories to healthcare providers. The Sensei system received FDA approval in May 2007, and Cary Vance was appointed President and CEO in May 2014, following Christopher P. Lowe's tenure as interim CEO. Ultimately, the company was acquired by Auris Surgical Robotics in 2017 for $80 million, concluding its independent operations. Hansen Medical was founded in 2002 by Fred Moll.
Key people at Hansen Medical.
Hansen Medical is a technology company specializing in robotic systems for catheter-based medical procedures, primarily in the cardiovascular and electrophysiology (EP) fields. Its flagship products include the Sensei Robotic System and the Magellan Robotic System, designed to improve the precision, safety, and efficacy of minimally invasive interventions such as the treatment of abnormal heart rhythms (arrhythmias) and peripheral vascular procedures. Hansen Medical serves hospitals, physicians, and patients by enabling more complex procedures to be performed with greater ease and reduced risk, including lowering radiation exposure to physicians. The company has demonstrated growth momentum through regulatory approvals, commercial shipments, and eventual acquisition by Auris Health, which expanded its robotic technology portfolio[1][2][3].
Founded in 2002 by Dr. Fred Moll, Hansen Medical emerged from the vision to pioneer flexible robotic technology for medical applications. Dr. Moll brought expertise in medical robotics, which shaped the company’s focus on catheter-based robotic systems. Early traction came with the development and CE Mark approval of the Sensei system in 2006, followed by commercial shipments targeting electrophysiology procedures. The company’s innovation in robotic catheter control marked a pivotal moment, enabling physicians to perform complex interventions with enhanced precision and safety. Hansen Medical’s evolution culminated in its acquisition by Auris Health in 2016, integrating its technology into broader robotic platforms for diagnostic and therapeutic procedures[1][2].
Hansen Medical rides the trend of robotic-assisted minimally invasive surgery and intervention, a growing segment driven by demand for safer, more precise, and less invasive medical procedures. The timing aligned with advances in robotics, imaging, and catheter technologies, as well as increasing clinical acceptance of robotic systems. Market forces such as rising cardiovascular disease prevalence and the need for improved procedural outcomes favor Hansen’s solutions. By pushing the boundaries of intravascular robotics, Hansen Medical influenced the broader ecosystem, accelerating adoption of robotic platforms in interventional cardiology and electrophysiology and inspiring further innovation in medical robotics[1][2][3].
Following its acquisition by Auris Health, Hansen Medical’s technology contributed to the development of the Monarch™ Platform, expanding robotic applications into bronchoscopic procedures. Looking ahead, the integration of robotic systems with advanced imaging, AI, and data analytics will likely shape the future trajectory of companies like Hansen Medical. Trends such as personalized medicine, remote interventions, and automation in healthcare will further enhance the impact of robotic catheter systems. Hansen Medical’s legacy positions it well to influence the evolution of minimally invasive robotic interventions across multiple specialties, continuing to improve patient outcomes and procedural efficiency[2][3].
